Principal Regulatory Officer Mr. Abel Ndego explained that although Postinor 2 is commonly used to prevent pregnancies, this particular version has not been approved by the Authority.
Because it is unregistered, the FDA cannot verify its safety or effectiveness. After conducting quality checks, the FDA found that the Active Pharmaceutical Ingredient (API) in this version is not at the required level to prevent pregnancy effectively.
"Using this product will not provide the intended pharmaceutical outcome," Mr. Ndego said during the launch of the Goodlife Health Fair in Bolgatanga. The three-day event, organized by the Regional Health Directorate and NORSAAC under USAID's Accelerating Social and Behavior Change (ASBC) program, aimed to promote health and encourage positive health behaviors.
The event's theme was “Promoting good health through uptake of positive health behavior.” Mr. Ndego urged the public to purchase medicines from accredited and licensed outlets, emphasizing that proper storage is critical to ensuring the efficacy of pharmaceutical products. He highlighted that improper storage, such as keeping children's syrups in warm kitchen environments instead of cool places like refrigerators, can diminish their effectiveness.
At the event, FDA officials also showcased unregulated products to raise awareness about the dangers they pose. Mr. Ndego pointed out a product with images of male genitalia on the packaging, stressing that it was unapproved by the FDA. He expressed concern that despite its explicit packaging, many people still buy such products under the misconception that they will enhance their sexual performance, warning of the serious health risks involved.
Credit:Graphic Online.
